ARTICLE | Company News
Magellan Bio, miacom diagnostics GmbH sales and marketing update
April 18, 2011 7:00 AM UTC
Magellan received exclusive commercialization rights to miacom's Bacteremia and Fungimia panels in the U.S. and Canada to identify sepsis-related pathogens for research use only. Further terms were no...